Worldwide burden of gynaecological cancer: The size of the problem
Worldwide burden of gynaecological cancer: The size of the problem
复制标题
DOI：
10.1016/j.bpobgyn.2005.10.007
复制
发表时间：
2006-04-01
影响因子：
5.5
通讯作者：
Ferlay, J
中科院分区：
文献类型：
--
作者：
Sankaranarayanan, R;Ferlay, J
对癌症负担的估计对于确定疾病控制的优先顺序是有价值的。国际癌症研究机构提供的全球癌症综合统计数据表明，2002年全球估计新增癌症病例510万例、癌症死亡290万例和5年流行癌症病例1300万例中，妇科癌症占19%。宫颈癌新发病例49.3万例，死亡27.3万例；子宫体癌新发病例19.9万例，死亡50000例；卵巢癌新发病例20.4万例，死亡12.5万例；阴道癌、外阴癌和绒毛膜癌共45900例。80%以上的宫颈癌病例发生在发展中国家，三分之二的子宫癌病例发生在发达国家。政治意愿和宣传投资于保健基础设施和人力资源，以改善服务的提供和可获得性，对于减轻低资源和中等资源国家目前的负担至关重要。
The estimation of cancer burden is valuable to set up priorities for disease control. The comprehensive global cancer statistics from the International Agency for Research on Cancer indicate that gynaecological cancers accounted for 19% of the 5.1 million estimated new cancer cases, 2.9 million cancer deaths and 13 million 5-year prevalent cancer cases among women in the world in 2002. Cervical cancer accounted for 493 000 new cases and 273 000 deaths; uterine body cancer for 199 000 new cases and 50 000 deaths; ovarian cancer for 204 000 new cases and 125 000 deaths; cancers of the vagina, vulva and choriocarcinoma together constituted 45 900 cases. More than 80% of the cervical cancer cases occurred in developing countries and two-thirds of corpus uteri cases occurred in the developed world. Political will and advocacy to invest in healthcare infrastructure and human resources to improve service delivery and accessibility are vital to reduce the current burden in low- and medium-resource countries.